Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Capizzi

Showing results (81-90 of 127) with videos related to

Pageof 13
Sort By:
Cancer Research|November 15, 1990
Ether-linked phosphoglyceride content of human leukemia cellsM C Chabot, D G Greene, J K Brockschmidt, et al.
Seminars in Oncology|August 1, 1996
Effects of amifostine and paclitaxel on growth of human ovarian carcinoma xenografts in the severe combined immune-deficient mouse: preliminary resultsG D Paine, C W Taylor, M H Lopez, et al.
Medical and Pediatric Oncology|January 1, 1986
Ara-C syndrome during low-dose continuous infusion therapyB L Powell, P J Zekan, H B Muss, et al.
Blood|October 1, 1995
Amifostine improves the antileukemic therapeutic index of mafosfamide: implications for bone marrow purgingL Douay, C Hu, M C Giarratana, et al.
Obstetrics and Gynecology|September 1, 1988
Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic diseaseH D Homesley, J A Blessing, M Rettenmaier, et al.
Cancer|October 1, 1979
High dose cytosine arabinoside (HDARAC) in refractory acute leukemiaS A Rudnick, E C Cadman, R L Capizzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1983
Alteration of the pharmacokinetics of high-dose ara-C by its metabolite, high ara-U in patients with acute leukemiaR L Capizzi, J L Yang, E Cheng, et al.
Infection Control and Hospital Epidemiology|May 1, 1990
Interaction of granulocytopenia and construction activity as risk factors for nosocomial invasive filamentous fungal disease in patients with hematologic disordersS F Weber, J E Peacock, K A Do, et al.
Cytometry|January 1, 1990
Bromodeoxyuridine incorporation into DNA of human leukemia cells is not concentration dependentB L Powell, B W Gregory, T E Kute, et al.
Cancer|March 15, 1983
High-dose methotrexate in small cell lung cancer. Lack of efficacy in preventing CNS relapseE S Neijstrom, R L Capizzi, S A Rudnick, et al.
Pageof 13

Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
Cancer Research|November 15, 1990
Ether-linked phosphoglyceride content of human leukemia cellsM C Chabot, D G Greene, J K Brockschmidt, et al.
Seminars in Oncology|August 1, 1996
Effects of amifostine and paclitaxel on growth of human ovarian carcinoma xenografts in the severe combined immune-deficient mouse: preliminary resultsG D Paine, C W Taylor, M H Lopez, et al.
Medical and Pediatric Oncology|January 1, 1986
Ara-C syndrome during low-dose continuous infusion therapyB L Powell, P J Zekan, H B Muss, et al.
Blood|October 1, 1995
Amifostine improves the antileukemic therapeutic index of mafosfamide: implications for bone marrow purgingL Douay, C Hu, M C Giarratana, et al.
Obstetrics and Gynecology|September 1, 1988
Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic diseaseH D Homesley, J A Blessing, M Rettenmaier, et al.
Cancer|October 1, 1979
High dose cytosine arabinoside (HDARAC) in refractory acute leukemiaS A Rudnick, E C Cadman, R L Capizzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1983
Alteration of the pharmacokinetics of high-dose ara-C by its metabolite, high ara-U in patients with acute leukemiaR L Capizzi, J L Yang, E Cheng, et al.
Infection Control and Hospital Epidemiology|May 1, 1990
Interaction of granulocytopenia and construction activity as risk factors for nosocomial invasive filamentous fungal disease in patients with hematologic disordersS F Weber, J E Peacock, K A Do, et al.
Cytometry|January 1, 1990
Bromodeoxyuridine incorporation into DNA of human leukemia cells is not concentration dependentB L Powell, B W Gregory, T E Kute, et al.
Cancer|March 15, 1983
High-dose methotrexate in small cell lung cancer. Lack of efficacy in preventing CNS relapseE S Neijstrom, R L Capizzi, S A Rudnick, et al.
Pageof 13